269 related articles for article (PubMed ID: 23670834)
1. What is the role of molecular markers in the management of "indeterminate" thyroid nodules?
Daniels GH
Cancer Cytopathol; 2013 May; 121(5):223-4. PubMed ID: 23670834
[No Abstract] [Full Text] [Related]
2. Can a gene-expression classifier with high negative predictive value solve the indeterminate thyroid fine-needle aspiration dilemma?
Faquin WC
Cancer Cytopathol; 2013 Mar; 121(3):116-9. PubMed ID: 23364882
[TBL] [Abstract][Full Text] [Related]
3. A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration.
Keutgen XM; Filicori F; Crowley MJ; Wang Y; Scognamiglio T; Hoda R; Buitrago D; Cooper D; Zeiger MA; Zarnegar R; Elemento O; Fahey TJ
Clin Cancer Res; 2012 Apr; 18(7):2032-8. PubMed ID: 22351693
[TBL] [Abstract][Full Text] [Related]
4. [Dignity of thyroid nodules: diagnostic gain by molecular fine needle aspiration cytology].
Eszlinger M; Ruschenburg I; Paschke R
Dtsch Med Wochenschr; 2013 Oct; 138(40):2003-6. PubMed ID: 24065405
[No Abstract] [Full Text] [Related]
5. Utility of molecular testing in the management of thyroid nodules - a clinical perspective.
Elaraj D; Nayar R; Sturgeon C
Cytopathology; 2015 Oct; 26(5):284-7. PubMed ID: 26399862
[No Abstract] [Full Text] [Related]
6. Getting more out of molecular testing for indeterminate thyroid nodules.
Angell TE
Cancer Cytopathol; 2019 Sep; 127(9):555-556. PubMed ID: 31237737
[No Abstract] [Full Text] [Related]
7. Centrifuged supernatants from FNA provide a liquid biopsy option for clinical next-generation sequencing of thyroid nodules.
Ye W; Hannigan B; Zalles S; Mehrotra M; Barkoh BA; Williams MD; Cabanillas ME; Edeiken-Monroe B; Hu P; Duose D; Wistuba II; Medeiros LJ; Stewart J; Luthra R; Roy-Chowdhuri S
Cancer Cytopathol; 2019 Mar; 127(3):146-160. PubMed ID: 30620446
[TBL] [Abstract][Full Text] [Related]
8. Benign call rate and molecular test result distribution of ThyroSeq v3.
Ohori NP; Landau MS; Carty SE; Yip L; LeBeau SO; Manroa P; Seethala RR; Schoedel KE; Nikiforova MN; Nikiforov YE
Cancer Cytopathol; 2019 Mar; 127(3):161-168. PubMed ID: 30561907
[TBL] [Abstract][Full Text] [Related]
9. The Role of Molecular Testing for the Indeterminate Thyroid FNA.
Rossi ED; Pantanowitz L; Faquin WC
Genes (Basel); 2019 Sep; 10(10):. PubMed ID: 31547603
[TBL] [Abstract][Full Text] [Related]
10. Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns.
Eszlinger M; Paschke R
Mol Cell Endocrinol; 2010 Jun; 322(1-2):29-37. PubMed ID: 20083161
[TBL] [Abstract][Full Text] [Related]
11. Genetic markers differentiating follicular thyroid carcinoma from benign lesions.
Freitas BC; Cerutti JM
Mol Cell Endocrinol; 2010 May; 321(1):77-85. PubMed ID: 19932149
[TBL] [Abstract][Full Text] [Related]
12. The role of genetic markers in the evaluation and management of thyroid nodules.
Parangi S; Suh H
Surg Clin North Am; 2014 Jun; 94(3):515-28. PubMed ID: 24857574
[TBL] [Abstract][Full Text] [Related]
13. Differentiating benign from malignant thyroid nodules using micro ribonucleic acid amplification in residual cells obtained by fine needle aspiration biopsy.
Mazeh H; Levy Y; Mizrahi I; Appelbaum L; Ilyayev N; Halle D; Freund HR; Nissan A
J Surg Res; 2013 Apr; 180(2):216-21. PubMed ID: 22626557
[TBL] [Abstract][Full Text] [Related]
14. New technology in thyroid fine-needle aspiration.
Poller DN
J Clin Pathol; 2014 Jun; 67(6):457. PubMed ID: 24695840
[No Abstract] [Full Text] [Related]
15. Molecular testing for thyroid nodules: Review and current state.
Roth MY; Witt RL; Steward DL
Cancer; 2018 Mar; 124(5):888-898. PubMed ID: 29278433
[TBL] [Abstract][Full Text] [Related]
16. Contemporary diagnostic approach to the thyroid nodule.
Rosen JE; Stone MD
J Surg Oncol; 2006 Dec; 94(8):649-61. PubMed ID: 17131409
[TBL] [Abstract][Full Text] [Related]
17. Whole-transcriptome profiling of thyroid nodules identifies expression-based signatures for accurate thyroid cancer diagnosis.
Wiseman SM; Haddad Z; Walker B; Vergara IA; Sierocinski T; Crisan A; Ghadessi M; Dao P; Zimmermann B; Triche TJ; Erho N; Davicioni E
J Clin Endocrinol Metab; 2013 Oct; 98(10):4072-9. PubMed ID: 23928671
[TBL] [Abstract][Full Text] [Related]
18. The quest for diagnostic molecular markers for thyroid nodules with indeterminate or suspicious cytology.
Kouniavsky G; Zeiger MA
J Surg Oncol; 2012 Apr; 105(5):438-43. PubMed ID: 22441894
[TBL] [Abstract][Full Text] [Related]
19. Extending expressed RNA genomics from surgical decision making for cytologically indeterminate thyroid nodules to targeting therapies for metastatic thyroid cancer.
Ali SZ; Siperstein A; Sadow PM; Golding AC; Kennedy GC; Kloos RT; Ladenson PW
Cancer Cytopathol; 2019 Jun; 127(6):362-369. PubMed ID: 31017745
[TBL] [Abstract][Full Text] [Related]
20. Molecular diagnosis for indeterminate thyroid nodules on fine needle aspiration: advances and limitations.
Keutgen XM; Filicori F; Fahey TJ
Expert Rev Mol Diagn; 2013 Jul; 13(6):613-23. PubMed ID: 23895130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
